Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius

Evidence from epidemiologic studies that central obesity precedes future metabolic change and does not occur concurrently with the appearance of the blood pressure, glucose, and lipid abnormalities that characterize the metabolic syndrome (MetS) has been lacking. Longitudinal surveys were conducted in Mauritius in 1987, 1992, and 1998, and in Australia in 2000 and 2005 (AusDiab). This analysis included men and women (aged 25 years) in three cohorts: AusDiab 2000&ndash;2005 (n = 5,039), Mauritius 1987&ndash;1992 (n = 2,849), and Mauritius 1987&ndash;1998 (n = 1,999). MetS components included waist circumference, systolic blood pressure, fasting and 2-h postload plasma glucose, high-density lipoprotein (HDL) cholesterol, triglycerides, and homeostasis model assessment of insulin sensitivity (HOMA-S) (representing insulin sensitivity). Linear regression was used to determine which baseline components predicted deterioration in other MetS components over 5 years in AusDiab and 5 and 11 years in Mauritius, adjusted for age, sex, and ethnic group. Baseline waist circumference predicted deterioration (P &lt; 0.01) in four of the other six MetS variables tested in AusDiab, five of six in Mauritius 1987&ndash;1992, and four of six in Mauritius 1987&ndash;1998. In contrast, an increase in waist circumference between baseline and follow-up was only predicted by insulin sensitivity (HOMA-S) at baseline, and only in one of the three cohorts. These results suggest that central obesity plays a central role in the development of the MetS and appears to precede the appearance of the other MetS components.<br /

Low-cost inorganic cation exchange membrane for electrodialysis: optimum processing temperature for the cation exchanger

The optimum temperature for fixing zirconium phosphate, obtained by precipitation, on a low-cost ceramic support was determined in order to obtain an inorganic cation exchange membrane for electrodialysis. Zirconium phosphate ion exchange capacity maximised between 450 and 550°C, thus it was considered the optimum processing temperature. The origin of this maximum was investigated by means of X-ray diffraction and termogravimetry and evolved gas analysis. Zirconium phosphate formation by precipitation in the porous network of the support was verified by scanning electron microscopy and energy dispersive X-ray analysis and mercury intrusion porosimetry. The membrane obtained after thermal treatment at 450°C displayed selectivity to the cations present in the spent rinse water of the chromium plating process. This property allows the recovery of chromium by removing the cations through the cation exchange ceramic membrane.The authors wish to express their gratitude to the Spanish Ministry of Science and Innovation for the support given to the research study (National Basic Research Programme, Ref. CTQ2008-06750-C02-02), as well as for the FPU student grant awarded to one of the authors (Ref.: AP2009-4409).Mestre, S.; Sales, S.; Palacios, M.; Lorente, M.; Mallol, G.; Pérez-Herranz, V. (2013). Low-cost inorganic cation exchange membrane for electrodialysis: optimum processing temperature for the cation exchanger. Desalination and Water Treatment. 51(16-18):3317-3324. https://doi.org/10.1080/19443994.2012.749177S331733245116-18Strathmann, H. (2010). Electromembrane Processes: Basic Aspects and Applications. Comprehensive Membrane Science and Engineering, 391-429. doi:10.1016/b978-0-08-093250-7.00048-7Drioli, E., & Fontananova, E. (s. f.). Integrated Membrane Processes. Membrane Operations, 265-283. doi:10.1002/9783527626779.ch12Strathmann, H. (s. f.). Fundamentals in Electromembrane Separation Processes. Membrane Operations, 83-119. doi:10.1002/9783527626779.ch5Alberti, G., Casciola, M., Costantino, U., & Levi, G. (1978). Inorganic ion exchange membranes consisting of microcrystals of zirconium phosphate supported by Kynar®. Journal of Membrane Science, 3(2), 179-190. doi:10.1016/s0376-7388(00)83021-5Semiat, R., & Hasson, D. (s. f.). Seawater and Brackish-Water Desalination with Membrane Operations. Membrane Operations, 221-243. doi:10.1002/9783527626779.ch10Bregman, J. ., & Braman, R. . (1965). Inorganic ion exchange membranes. Journal of Colloid Science, 20(9), 913-922. doi:10.1016/0095-8522(65)90064-4Bishop, H. K., Bittles, J. A., & Guter, G. A. (1969). Investigation of inorganic ion exchange membranes for electrodialysis. Desalination, 6(3), 369-380. doi:10.1016/s0011-9164(00)80226-xRajan, K. S., Boies, D. B., Casolo, A. J., & Bregman, J. . (1966). Inorganic ion-exchange membranes and their application to electrodialysis. Desalination, 1(3), 231-246. doi:10.1016/s0011-9164(00)80255-6INAMUDDIN, KHAN, S., SIDDIQUI, W., & KHAN, A. (2007). Synthesis, characterization and ion-exchange properties of a new and novel ‘organic–inorganic’ hybrid cation-exchanger: Nylon-6,6, Zr(IV) phosphate. Talanta, 71(2), 841-847. doi:10.1016/j.talanta.2006.05.042HELEN, M., VISWANATHAN, B., & MURTHY, S. (2007). Synthesis and characterization of composite membranes based on α-zirconium phosphate and silicotungstic acid. Journal of Membrane Science, 292(1-2), 98-105. doi:10.1016/j.memsci.2007.01.018Yu.S. Dzyaz’ko, V.N. Belyakov, N.V. Stefanyak, S.L. Vasilyuk, Anion-exchange properties of composite ceramic membranes containing hydrated zirconium dioxide, Russ. J. Appl. Chem. 79 (2006) 769–773.Linkov, V. ., & Belyakov, V. . (2001). Novel ceramic membranes for electrodialysis. Separation and Purification Technology, 25(1-3), 57-63. doi:10.1016/s1383-5866(01)00090-9Linkov, V. M., Dzyaz’ko, Y. S., Belyakov, V. N., & Atamanyuk, V. Y. (2007). Inorganic composite membranes for electrodialytic desaltination. Russian Journal of Applied Chemistry, 80(4), 576-581. doi:10.1134/s1070427207040118El-Sourougy, M. R., Zaki, E. E., & Aly, H. F. (1997). Transport characteristics of ceramic supported zirconium phosphate membrane. Journal of Membrane Science, 126(1), 107-113. doi:10.1016/s0376-7388(96)00273-6Sánchez, E., Mestre, S., Pérez-Herranz, V., & García-Gabaldón, M. (2005). Síntesis de membranas cerámicas para la regeneración de baños de cromado agotados. Boletín de la Sociedad Española de Cerámica y Vidrio, 44(6), 409-414. doi:10.3989/cyv.2005.v44.i6.340Sánchez, E., Mestre, S., Pérez-Herranz, V., Reyes, H., & Añó, E. (2006). Membrane electrochemical reactor for continuous regeneration of spent chromium plating baths. Desalination, 200(1-3), 668-670. doi:10.1016/j.desal.2006.03.475Alberti, G., Casciola, M., Costantino, U., & Vivani, R. (1996). Layered and pillared metal(IV) phosphates and phosphonates. Advanced Materials, 8(4), 291-303. doi:10.1002/adma.19960080405Alberti, G., & Torracca, E. (1968). Crystalline insoluble salts of polybasic metals - II. Synthesis of crystalline zirconium or titanium phosphate by direct precipitation. Journal of Inorganic and Nuclear Chemistry, 30(1), 317-318. doi:10.1016/0022-1902(68)80096-xTrobajo, C., Khainakov, S. A., Espina, A., & García, J. R. (2000). On the Synthesis of α-Zirconium Phosphate. Chemistry of Materials, 12(6), 1787-1790. doi:10.1021/cm0010093Alberti, G. (1978). Syntheses, crystalline structure, and ion-exchange properties of insoluble acid salts of tetravalent metals and their salt forms. Accounts of Chemical Research, 11(4), 163-170. doi:10.1021/ar50124a007Rajeh, A. O., & szirtes, L. (1995). Investigations of crystalline structure of gamma-zirconium phosphate. Journal of Radioanalytical and Nuclear Chemistry Articles, 196(2), 319-322. doi:10.1007/bf02038050Krogh Andersen, A. M., Norby, P., Hanson, J. C., & Vogt, T. (1998). Preparation and Characterization of a New 3-Dimensional Zirconium Hydrogen Phosphate, τ-Zr(HPO4)2. Determination of the Complete Crystal Structure Combining Synchrotron X-ray Single-Crystal Diffraction and Neutron Powder Diffraction. Inorganic Chemistry, 37(5), 876-881. doi:10.1021/ic971060hFeng, Y., He, W., Zhang, X., Jia, X., & Zhao, H. (2007). The preparation of nanoparticle zirconium phosphate. Materials Letters, 61(14-15), 3258-3261. doi:10.1016/j.matlet.2006.11.132Clearfield, A. (2000). INORGANIC ION EXCHANGERS, PAST, PRESENT, AND FUTURE. Solvent Extraction and Ion Exchange, 18(4), 655-678. doi:10.1080/07366290008934702Szirtes, L., Shakshooki, S. K., Szeleczky, A. M., & Rajeh, A. O. (1998). Thermoanalyncal Investigation of Some Layered Zirconium Salts and Their Various Derivatives I. Journal of Thermal Analysis and Calorimetry, 51(2), 503-515. doi:10.1007/bf03340188Al-Othman, A., Tremblay, A. Y., Pell, W., Letaief, S., Burchell, T. J., Peppley, B. A., & Ternan, M. (2010). Zirconium phosphate as the proton conducting material in direct hydrocarbon polymer electrolyte membrane fuel cells operating above the boiling point of water. Journal of Power Sources, 195(9), 2520-2525. doi:10.1016/j.jpowsour.2009.11.052Thakkar, R., Patel, H., & Chudasama, U. (2007). A comparative study of proton transport properties of zirconium phosphate and its metal exchanged phases. Bulletin of Materials Science, 30(3), 205-209. doi:10.1007/s12034-007-0036-3Jiang, P., Pan, B., Pan, B., Zhang, W., & Zhang, Q. (2008). A comparative study on lead sorption by amorphous and crystalline zirconium phosphates. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 322(1-3), 108-112. doi:10.1016/j.colsurfa.2008.02.035García-Gabaldón, M., Pérez-Herranz, V., García-Antón, J., & Guiñón, J. L. (2009). Use of ion-exchange membranes for the removal of tin from spent activating solutions. Desalination and Water Treatment, 3(1-3), 150-156. doi:10.5004/dwt.2009.453García-Gabaldón, M., Pérez-Herranz, V., García-Antón, J., & Guiñón, J. L. (2009). Effect of hydrochloric acid on the transport properties of tin through ion-exchange membranes. Desalination and Water Treatment, 10(1-3), 73-79. doi:10.5004/dwt.2009.69

Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients

WSTĘP. Celem badania była ocena wpływu przewlekłego doustnego stosowania L-argininy, działającej przez normalizację szlaku NO/cykliczny 3&#8217;,5&#8217;-guanozyno monofosforan (cGMP), na poprawę insulinowrażliwości obwodowej i wątrobowej u 12 szczupłych osób chorych na cukrzycę typu 2. MATERIAŁ I METODY. Badanie, przeprowadzone metodą podwójnie ślepej próby, trwało 3 miesiące. W pierwszym miesiącu chorych leczono typową dietą cukrzycową. Następnie losowo przydzielono ich do dwóch grup. W grupie 1 przez 2 miesiące stosowano typową dietę i placebo (doustnie 3 × d.). W grupie 2 pacjentów leczono przez miesiąc dietą i placebo (doustnie 3 × d.) i następnie przez miesiąc dietą i L-argininą (3 g 3 × d.). Po pierwszymi i drugim miesiącu wykonano badanie za pomocą klamry euglikemiczno-hiperinsulinemicznej z jednoczesnym wlewem dożylnym znakowanej izotopowo glukozy (glukoza 6,6- 2H2). Grupą kontrolną stanowiło 10 zdrowych osób, u których również wykonano badanie za pomocą klamry. WYNIKI. W grupie 1 w czasie badania nie zaobserwowano zmian podstawowego stężenia cGMP, skurczowego ciśnienia tętniczego, przepływu krwi w przedramieniu, wykorzystania glukozy i endogennej produkcji glukozy. W grupie 2 przyjmowanie L-argininy spowodowało normalizację podstawowego stężenia cGMP, poprawę przepływu w przedramieniu o 36%, oraz wykorzystania glukozy w badaniu metodą klamry metabolicznej o 34%, jak również obniżenie skurczowego ciśnienia tętniczego i endogennej produkcji glukozy odpowiednio o 14 i 29%. Pomimo tego w porównaniu z grupą kontrolną podawanie L-argininy nie normalizuje całkowicie metabolizmu glukozy. WNIOSKI. Podawanie L-argininy u chorych na cukrzycę typu 2 znacznie poprawia insulinowrażliwość obwodową i wątrobową, lecz nie normalizuje jej całkowicie.INTRODUCTION. The aim of this study was to evaluate whether long-term administration of L-arginine acting through a normalization of NO/cyclic-guanosine- 3&#8217;,5&#8217;-cyclic monophosphate (cGMP) pathway was able to ameliorate peripheral and hepatic insulin sensitivity in 12 lean type 2 diabetic patients. MATERIAL AND METHODS. A double-blind study was performed for 3 months. In the first month, patients were treated with their usual diet. Then they were randomly allocated into two groups. In group 1, patients were treated with diet plus placebo (orally three times per day) for 2 months. In group 2 patients were treated for 1 month with diet plus placebo (orally, three times per day) and then for 1 month with diet plus L-arginine (3 g three times per day). At the end of the first and the second month of therapy, patients underwent a euglycemic-hyperinsulinemic clamp combined with [6,6-2H2] glucose infusion. A total of 10 normal subjects underwent the same test as control subjects. RESULTS. In group 1, no changes in basal cGMP levels, systolic blood pressure, forearm blood flow, glucose disposal, and endogenous glucose production were observed throughout. In group 2, L-arginine normalized basal cGMP levels and significantly increased forearm blood flow by 36% and glucose disposal during the clamp by 34%, whereas it decreased systolic blood pressure, and endogenous glucose production by 14 and 29%, respectively. However, compared with normal subjects, L-arginine treatment was not able to completely overcome the defect in glucose disposal. CONCLUSIONS. L-arginine treatment significantly improves but does not completely normalize peripheral and hepatic insulin sensitivity in type 2 diabetic patients

Cut-points for waist circumference in Europids and South Asians

There is little strong evidence that currently recommended higher waist circumference cut-points for Europids compared with South Asians are associated with similar risk for type 2 diabetes. This study was designed to provide such evidence. Longitudinal studies over 5 years were conducted among 5,515 Europid and 2,214 ethnically South Asian participants. Age-standardized diabetes incidence at different levels of waist circumference and incidence difference relative to a reference value were calculated. The Youden Index was used to determine waist circumference cut-points. At currently recommended cut-points, estimated annual diabetes incidence for a 50-year-old Europid was &lt;0.6% for both sexes, and for a 50-year-old South Asian, 5.8% for men and 2.1% for women. Annual diabetes incidence of 1% was observed for a 50 year old at a waist circumference 35&ndash;40 cm greater in Europid compared to South Asian men and women. Incidence difference between recommended cut-points and a reference value (80 cm in men, 70 cm in women) was 0.3 and 4.4% per year for Europid and South Asian men, and 0.2 and 0.8% per year for Europid and South Asian women, respectively. Waist circumference cut-points chosen using the Youden Index were shown to be dependent on obesity levels in the population. The much higher observed risk of diabetes in South Asians compared to Europids at the respective recommended waist circumference cut-points suggests that differences between them should be greater. Approaches that use the Youden Index to select waist circumference cut-points are inappropriate and should not be used for this purpose.<br /

Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria

OBJECTIVE—We investigated stroke mortality in individuals in different categories of glycemia and compared hazard ratios (HRs) corresponding to a 1-SD increase in 2-h plasma glucose and fasting plasma glucose (FPG) criteria